Literature DB >> 14261407

METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.

D L SMITH, T J VECCHIO, A A FORIST.   

Abstract

Entities:  

Keywords:  ACETOHEXAMIDE; ANTIDIABETICS; BLOOD; CHLORPROPAMIDE; EXCRETION; METABOLISM; TOLAZAMIDE; TOLBUTAMIDE; URINE

Mesh:

Substances:

Year:  1965        PMID: 14261407     DOI: 10.1016/0026-0495(65)90063-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

Review 1.  Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 3.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

Review 5.  The management of diabetes mellitus in older individuals.

Authors:  J E Morley; H M Perry
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 6.  Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.

Authors:  A D Harrower
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 7.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.